These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9343239)
21. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405 [TBL] [Abstract][Full Text] [Related]
22. In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein. Sekiya S; Nishikawa F; Noda K; Kumar PK; Yokoyama T; Nishikawa S Nucleic Acids Symp Ser (Oxf); 2005; (49):361-2. PubMed ID: 17150783 [TBL] [Abstract][Full Text] [Related]
23. Solution structure of Syrian hamster prion protein rPrP(90-231). Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323 [TBL] [Abstract][Full Text] [Related]
24. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle. Prusiner SB Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599 [TBL] [Abstract][Full Text] [Related]
25. The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Rieger R; Edenhofer F; Lasmézas CI; Weiss S Nat Med; 1997 Dec; 3(12):1383-8. PubMed ID: 9396609 [TBL] [Abstract][Full Text] [Related]
26. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Kocisko DA; Lansbury PT; Caughey B Biochemistry; 1996 Oct; 35(41):13434-42. PubMed ID: 8873612 [TBL] [Abstract][Full Text] [Related]
27. Role of the PrP gene in transmissible spongiform encephalopathies. Weissmann C; Büeler H; Fischer M; Aguet M Intervirology; 1993; 35(1-4):164-75. PubMed ID: 8407244 [TBL] [Abstract][Full Text] [Related]
28. Large-scale production, purification and refolding of the full-length cellular prion protein from Syrian golden hamster in Escherichia coli using the glutathione S-transferase-fusion system. Völkel D; Blankenfeldt W; Schomburg D Eur J Biochem; 1998 Jan; 251(1-2):462-71. PubMed ID: 9492319 [TBL] [Abstract][Full Text] [Related]
29. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. Harmeyer S; Pfaff E; Groschup MH J Gen Virol; 1998 Apr; 79 ( Pt 4)():937-45. PubMed ID: 9568991 [TBL] [Abstract][Full Text] [Related]
30. Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP Corda E; Du X; Shim SY; Klein AN; Siltberg-Liberles J; Gilch S Mol Neurobiol; 2018 Oct; 55(10):7758-7774. PubMed ID: 29460268 [TBL] [Abstract][Full Text] [Related]
31. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC. Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583 [TBL] [Abstract][Full Text] [Related]
34. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc. Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877 [TBL] [Abstract][Full Text] [Related]
35. Generation of monoclonal antibody recognized by the GXXXG motif (glycine zipper) of prion protein. Choi JK; Park SJ; Jun YC; Oh JM; Jeong BH; Lee HP; Park SN; Carp RI; Kim YS Hybridoma (Larchmt); 2006 Oct; 25(5):271-7. PubMed ID: 17044782 [TBL] [Abstract][Full Text] [Related]
37. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006 [TBL] [Abstract][Full Text] [Related]
38. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541 [TBL] [Abstract][Full Text] [Related]
39. Anti-PrP antibodies detected at terminal stage of prion-affected mouse. Sassa Y; Kataoka N; Inoshima Y; Ishiguro N Cell Immunol; 2010; 263(2):212-8. PubMed ID: 20417929 [TBL] [Abstract][Full Text] [Related]
40. Origins of binding specificity of the A1 heterogeneous nuclear ribonucleoprotein. Abdul-Manan N; O'Malley SM; Williams KR Biochemistry; 1996 Mar; 35(11):3545-54. PubMed ID: 8639505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]